相关实验视频

Updated: Jun 9, 2025

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Published on: May 16, 2018

针对过早卵巢衰竭而设计介质干细胞:克服挑战和创新治疗策略

Zijun Yuan¹, Yinping Zhang¹, Xinyu He¹

¹Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.

|October 31, 2024

概括

介质细胞干细胞 (MSCs) 对于治疗早产卵巢衰竭 (POF) 是有前途的,但需要了解细胞差异才能获得一致的结果. 本综述探讨了MSCs用于卵巢再生,重点是提高有效性和安全性.

科学领域:

生殖医学生殖医学
干细胞生物学干细胞生物学
再生医学是一种再生医学.

背景情况:

过早卵巢衰竭 (POF) 显著影响女性的生育能力和幸福感.
目前对POF的治疗方法有限,因此需要新的治疗策略.
介质细胞干细胞 (MSCs) 由于其指导和再生能力,为卵巢再生提供了潜力,但临床结果是可变的.

研究的目的:

为了改善POF治疗,研究MSC种群中的细胞异质性.
审查MSCs在卵巢再生中的有效性,安全性和伦理方面.
探索先进的MSC策略,包括遗传和组织工程.

主要方法:

综合性文献审查的临床前和临床试验涉及MSCs为POF.
在MSC中分析细胞异质性,以确定功能子群.
检查基因和组织工程MSC方法.

主要成果:

在POF治疗中MSC的疗效不一致,可能是由于MSC种群的异质性.
现有文献强调了对标准化协议的需要,以及对MSC机制的进一步研究.
基因和组织工程MSC为改善治疗结果提供了新的途径.

结论:

了解MSC异质性对于开发有针对性和有效的POF治疗至关重要.
需要进行进一步的研究和临床试验,以优化MSC为基础的卵巢再生疗法.
在POF中对MSC进行临床转化时,必须彻底评估伦理考虑和安全概况.

关键词:

基因工程是基因工程,是基因工程.不同质性的异质性介质细胞干细胞介质细胞干细胞过早的卵巢衰竭可能是早产卵巢衰竭.组织工程是组织工程.

更多相关视频

Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells

Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells

Published on: December 16, 2018

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...